BRLF1 109-117 (HLA-A*02:01)
Prices plus VAT plus shipping costs
Delivery time 2-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
- Order number: EP11139_1
Antigen Peptide BRLF1 109–117 HLA-A*02:01 (YVLDHLIVV) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. YVLDHLIVV is a linear peptidic epitope (epitope ID76333) studied as part of Replication and transcription activator from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity and tested in T cell assays as well as MHC ligand assay.Replication and transcription activator from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity and tested in T cell assays as well as MHC ligand assay.
Sequence: | YVLDHLIVV | |
Gene: | ATF7IP | |
Delivery: | 2-3 days | |
C-Terminus: | OH | |
N-Terminus: | H | |
Purity: | 95% | |
Amount: | 1 mg | |
Counter Ion: | TFA | |
Protein: | Activating transcription factor 7-interacting protein 1 | |
Species: | Human | |
Allele: | HLA-A*02:01 | |
Application : | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
Indication : | Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma |
Protocols and Tips
Data sheets